Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Mild Cognitive Impairment and Neuromodulation

NCT: NCT07691918 · ENROLLING_BY_INVITATION

NCT IDNCT07691918
StatusENROLLING_BY_INVITATION
Start Date2026-10
Completion2028-12
SponsorVirginia Polytechnic Institute and State University (OTHER)
First posted
Last updated

Brief Summary

This is a parallel, sham-controlled design of low-intensity focused ultrasound in patients with mild cognitive impairment (MCI). The study will evaluate safety, tolerability, and effects on cognitive function.

Frequently Asked Questions

What is Mild Cognitive Impairment and Neuromodulation?

Mild Cognitive Impairment and Neuromodulation is a clinical trial registered under NCT07691918. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07691918?

The current status of NCT07691918 (Mild Cognitive Impairment and Neuromodulation) is: ENROLLING_BY_INVITATION.

When did Mild Cognitive Impairment and Neuromodulation start?

Mild Cognitive Impairment and Neuromodulation started on 2026-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.